The Research and Development team at Adimab is dedicated to advancing antibody discovery and optimization through cutting-edge research and innovative methodologies. Comprised of a diverse group of scientists and research associates, the team focuses on engineering full-length human Immunoglobulin Gs, employing techniques in protein analytics, computational biology, and bioprocess engineering to enhance the efficacy and performance of therapeutic antibodies. Their collaborative efforts drive the continuous improvement of antibody technologies to meet the evolving needs of the biopharmaceutical industry.
View all